Progress in current situation and intervention measures of neonatal birth defect

JIANG Wen-jing; CHEN Yu-qing; YANG Jia-hui; SHEN Yan; WU Kai-mei; LI Xian-hong

doi:10.11852/zgetbjzz2020-1521

PDF(562 KB)

Chinese Journal of Child Health Care ›› 2021, Vol. 29 ›› Issue (12) : 1317-1320. DOI: 10.11852/zgetbjzz2020-1521

Review

Progress in current situation and intervention measures of neonatal birth defect

JIANG Wen-jing, CHEN Yu-qing, YANG Jia-hui, SHEN Yan, WU Kai-mei, LI Xian-hong

Author information +

History +

Abstract

Neonatal birth defect is a major public health issue around the world. This review describes the epidemiological prevalence,the intervention measures,and the challenges of the neonatal birth defect,so as to provide references for developing more culturally adaptive measures in future for Chinese government and health care professionals.

Key words

birth defect / congenital anomalies / intervention measures

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

JIANG Wen-jing, CHEN Yu-qing, YANG Jia-hui, SHEN Yan, WU Kai-mei, LI Xian-hong. Progress in current situation and intervention measures of neonatal birth defect[J]. Chinese Journal of Child Health Care. 2021, 29(12): 1317-1320 https://doi.org/10.11852/zgetbjzz2020-1521

References

[1] 杨美剑.妇女保健与优生优育研究进展[J].实用妇科内分泌杂志(电子版),2017,4(4):10-11.
[2] 中华人民共和国卫生部.中国出生缺陷防治报告 (2012)[R].北京:中华人民共和国卫生部,2012.
[3] 胡淑怡,杜莉,朱丽萍.国内外围孕期保健服务研究进展[J].中国妇幼保健,2019,34(1):220-222.
[4] World Health Organization. Congenital anomalies[R].Geneva: World Health Organization,2016.
[5] Baldacci S,Gorini F,Santoro M,et al.Environmental and individual exposure and the risk of congenital anomalies: a review of recent epidemiologicalevidence[J].Epidemiol Prev,2018,42(3-4Suppl1):1-34.
[6] Almli LM. Association between infant mortality attributable to birth defects and payment source for delivery-United States,2011-2013[J].MMWR Morb Mortal Wkly Rep,2017,66(3):84.
[7] Lamichhane DK,Leem JH,Park M,et al.Increased prevalence of some birth defects in Korea,2009-2010[J].BMC Pregnancy Childbirth,2016,16(1):1-10.
[8] World Health Organization.Birth defect[R].Geneva:World Health Organization,2019.
[9] Kurdi A,Majeed-Saidan M. World birth defects day. Towards a national registry for birth defects in Saudi Arabia[J].Saudi Med J,2015,36(2):143-145.
[10] 刘永红,陈远明.我国干预新生儿出生缺陷工程的现状与进展[J].大众科技,2018,20(9):58-59.
[11] 孙冰洁.我国22种出生缺陷大幅下降:更多重大出生缺陷病种有望纳入大病专项救治[EB/OL].[2019-07-26].http://guoqing.china.com.cn/2019-07/26/content_75036256.htm
[12] CDC.Announcement: national birth defects prevention month and folic acid awareness week-January 2018[J].MMWRMorb Mortal Wkly Rep,2018,66(51-52):1411.
[13] Grant GB,Desai S,Dumolard L,et al.Progress toward rubella and congenital rubella syndrome control and elimination-worldwide,2000-2018[J].MMWR Morb Mortal Wkly Rep,2019,68(39):855-859.
[14] Kinsner-Ovaskainen A,Lanzoni M,Garne EE,et al.A sustainable solution for the activities of the European network for surveillance of congenital anomalies: EUROCAT as part of the EU Platform on Rare Diseases Registration[J].Eur J Med Genet,2018,61(9):513-517.
[15] Tucker FD,Morris JK,Neville A,et al.Correction to: EUROCAT: an update on its functions and activities[J].J Community Genet,2019,10(2):407-410.
[16] Yoon PW.The national birth defects prevention study[J].Public Health Rep,2001,116(90001):32-40.
[17] Tinker SC,Carmichael SL,Marlene A,et al.Next steps for birth defects research and prevention: The birth defects study to evaluate pregnancy exposures (BD-STEPS)[M].Birth Defects Res A Clin Mol Teratol,2015.
[18] Nitta H. Outline of the Japan environment and children's study andthe framework ofgenome analysis[J].Nihon Eiseigaku Zasshi,2016,71(1):91-93.
[19] Mezawa H,Tomotaki A,Yamamoto-Hanada K,et al.Prevalence of congenital anomalies in the Japan environment and children's study[J].J Epidemiol,2019,29(7):247-256.
[20] Johnson KJ,Lee JM,Ahsan K,et al.Pediatric cancer risk in association with birth defects:A systematic review[J].PLoS One,2017,12(7):e0181246.
[21] Zaidi S,Brueckner M.Genetics and genomics of congenital heart disease[J].Circ Res,2017,120(6):923-940.
[22] Thomford NE,Dzobo K,Yao NA,et al.Genomics and epigenomics of congenital heart defects: expert review and lessons learned in Africa[J].OMICS,2018,22(5):301-321.
[23] 国家卫生健康委员会.中国妇幼健康事业发展报告(2019)[R].北京:国家卫生健康委员会,2019.
[24] 程文.孕前健康体检的现状分析及孕前保健的模式研究[J].中国医药指南,2017,15(12):179-180.
[25] 刘帅妹,张瑞金,周青,等.精准医学与出生缺陷预防[J].实用预防医学,2019,26(2):132-135.
[26] 谢艳冰.分析产前胎儿系统超声筛查在减少出生缺陷中的临床应用[J].世界最新医学信息文摘,2019,19(74):201-202.
[27] 余宏盛,胡晞江.基于高通量测序技术应用于孕期无创产前筛查人群的结果分析[J].实用医学杂志,2019,35(3):433-436.
[28] 吴玥丽,张琳琳,李琳,等.高通量测序技术在无创性产前胎儿染色体缺失重复检测中的应用[J].中国计划生育学杂志,2019,27(6):789-792.
[29] 陈欢,吴畏.胚胎植入前遗传学检测技术的发展及临床应用[J].国际生殖健康/计划生育杂志,2019,38(4):300-304.
[30] 封纪珍,贾立云,王熙,等.石家庄地区128399例新生儿多种遗传代谢病串联质谱筛查结果分析[J].临床检验杂志,2020,38(5):344-349.
[31] 白文学,龙川江.江津区新生儿串联质谱法遗传代谢病筛查研究[J].数理医药学杂志,2019,32(8):1180-1182.
[32] 张亚果,苏星月,李婷,等.四川省部分地区新生儿遗传代谢病串联质谱筛查情况分析[J].中国儿童保健杂志,2020,28(7):809-812.
[33] 郭克建,周旋,陈西贵,等.济宁地区48297例新生儿串联质谱法遗传代谢疾病筛查的应用[J].中国优生与遗传杂志,2017,25(6):77-79.
[34] 白文学,龙川江.江津区新生儿串联质谱法遗传代谢病筛查研究[J].数理医药学杂志,2019,32(8):1180-1182.
[35] Qu-ming ZHAO,Xiao-jing MA,Xiao-ling GE,et al.Pulse oximetry with clinical assessment to screen for congenitalheart disease in neonates in China:a prospective study[J].Lancet,2014,384(9945):747-754.
[36] 姜晏,李璐,吴玉璘,等.出生缺陷生物样本库建设及管理实践[J].中国医药导报,2017,14(30):164-167.
[37] 刘艳红,叶庆.精准医疗时代下生物样本库的建设与发展特点[J].协和医学杂志,2021,12(2):254-259.